Neonatal salt‐wasting and 11 β‐hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)– CYP11B1 (11 β‐hydroxylase)

This article reports the case of a boy diagnosed at 1.8 years of age with congenital adrenal hyperplasia due to 11 β‐hydroxylase deficiency. The patient showed salt‐wasting episodes during the neonatal period. On molecular analysis, a homozygous deletion hybrid ( CYP11B2 – CYP11B1 ) involving the CYP11B locus at 8q24.3 was found. Southern blot analysis showed the break point of the chimera gene to be located before intron 5; sequence analysis identified it at exon 4 between codons 202 and 248. This CYP11B2 (5′)/ B1 (3′) hybrid should lack aldosterone synthase activity (due to the CYP11B1 residues at exons 5 and 6), and the enzyme it codes for should not be promoted by adrenocorticotropic hormone (ACTH) ( CYP11B2 promoter sequences). The patient phenotype – neonatal salt‐wasting and 11 β‐hydroxylase deficiency – is in agreement with this hybrid structure. This is the first time a homozygous deletion hybrid generated by unequal crossover has been described in exon 4. This genetic lesion appears to be the reciprocal product from the recombination event that causes glucocorticoid‐remediable aldosteronism, a duplication dominant allele ( CYP11B2 – CYP11B1 / B2 – CYP11B1 ) coding for additional aldosterone synthase activity regulated by ACTH. The clinical presentation of the condition in this patient contributes to the in vivo understanding of the regulation of this complex locus in which two ‘duplicated’ genes have evolved different regulatory and enzymatic activities involved in mineralocorticoid and glucocorticoid synthesis in the adrenal glands. The fact that this allele was first predicted and has now been documented clinically and molecularly in vivo is particularly noteworthy.